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ACQUIRED CARDIOVASCULAR DISEASENeurocognitive and neuroanatomic changes after off-pump versus
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1116Objective: It is unknown whether avoidance of cardiopulmonary bypass during coronary artery bypass grafting
affects cerebral injury or long-term neuropsychological function.
Methods: Two hundred unselected patients were randomized to off-pump coronary artery bypass or on-pump
coronary artery bypass grafting between March 2000 and August 2001. One hundred sixty-eight patients had
early postoperative brain magnetic resonance imaging. Eighty-seven returned after a mean of 7.5 years of
follow-up; 67 had repeat magnetic resonance imaging, and 76 had neuropsychological testing.
Results: There were 26 deaths among patients undergoing off-pump coronary artery bypass and 31 among
patients undergoing cardiopulmonary bypass as of March 2009. Seventy-six patients (41 undergoing cardiopul-
monary bypass and 35 undergoing off-pump coronary artery bypass) had neuropsychological testing at late
follow-up. Groups were similar in age, sex, depression, and IQ. Patients undergoing off-pump coronary artery
bypass showed better attention, performing better at tracking and mentally manipulating information (P¼.011).
Patients undergoing off-pump coronary artery bypass demonstrated better cognitive reasoning and made fewer
errors in reasoning (P ¼ .05); they also showed a trend toward better verbal learning (P ¼ .064). There were no
domains in which patients undergoing cardiopulmonary bypass outperformed those undergoing off-pump
coronary artery bypass. Early magnetic resonance imaging in 168 patients showed no significant differences be-
tween groups in temporal or frontal lobe atrophy, subcortical white matter lesions, or acute infarctions. There
were no significant differences between groups in atrophy over time or new subcortical white matter lesions
or infarctions. Acute perioperative cerebral infarctions were more common and atrophy more progressive during
follow-up among diabetic than nondiabetic patients.
Conclusions: After a mean of 7.5 years of follow-up, patients undergoing off-pump coronary artery bypass per-
formed better than those undergoing cardiopulmonary bypass in several neuropsychological domains; these dif-
ferences were small and of uncertain clinical importance. Early brain magnetic resonance imaging showed no
significant differences in acute cerebral infarctions between the off-pump coronary artery bypass and cardiopul-
monary bypass groups. (J Thorac Cardiovasc Surg 2011;141:1116-27)In an effort to avoid morbidity attributed to cardiopulmo-
nary bypass (CPB), aortic cannulation/clamping, hypother-
mic cardioplegic arrest, and systemic hemodilution,
off-pump coronary artery bypass (OPCAB) techniques
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The Journal of Thoracic and Cardiovascular Surreports of improved outcomes with OPCAB from
numerous centers3,4 and from the Society of Thoracic
Surgeons (STS) National Cardiac Database5 and the US
Veterans Administration database,6 adoption of OPCAB
plateaued at approximately 20% in 2004 and has not
changed significantly since that time.7 This might be due
in part to the technically challenging nature of OPCAB
and in part due to the lack of compelling reductions in major
adverse cardiac events (death, stroke, and myocardial in-
farction) among the low-risk patients enrolled in small, un-
derpowered randomized controlled trials comparing
OPCAB with conventional CABG techniques.8,9
One of the strong motivations to explore and adopt
OPCAB techniques has been the hope that avoidance of
CPB and reduced aortic manipulation would be associated
with reduced risk of perioperative stroke and neurocognitive
decline associated with coronary artery bypass surgery.10
Typically enrolling low-risk patients, randomized trials to
date have been underpowered to detect a difference ingery c May 2011
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
CSF ¼ cerebrospinal fluid
FLAIR ¼ fluid attenuated inversion recovery
MRI ¼ magnetic resonance imaging
OPCAB ¼ off-pump coronary artery bypass
RAVLT ¼ Rey Auditory Verbal Learning Test
ROI ¼ region of interest
SMART ¼ Surgical Management of Arterial
Revascularization Therapies
STS ¼ Society of Thoracic Surgeons
Puskas et al Acquired Cardiovascular Disease
A
C
Dperioperative stroke, an infrequently occurring end
point.9,11-15 Nonetheless, risk-adjusted retrospective reviews
of numerous large clinical databases have repeatedly demon-
strated a clinically and statistically significant reduction in
perioperative stroke for patients undergoing OPCAB
compared with conventional CABG during CPB.5,6,16,17
The early studies among these patients were legitimately
criticized because of their inability to account for
intraoperative conversion of patients from OPCAB to CPB
to report an intent-to-treat comparison. This potential source
of bias was addressed by the introduction of a data field in the
STS National Cardiac Database to report intraoperative con-
version and subsequently by the first intent-to-treat analysis
of the STS database, which confirmed an adjusted odds ratio
for stroke inpatients undergoingOPCABof0.65 (P<.001).16
Although it seems logical that elimination of CPB and re-
duction in aortic manipulation should reduce the risk of em-
bolic and ischemic stroke,18 it must also be acknowledged
that the specific technique for performing (or avoiding)
proximal anastomoses on the ascending aorta (including
single, double, or no aortic clamp) can have a significant
effect on stroke risk, especially in patients with atheroscle-
rosis of the ascending aorta, independent of the use or avoid-
ance of CPB during surgical coronary revascularization.19
Whether CABG causes neurocognitive decline20-22 is
contested, and several studies have reported similar change
from baseline neurocognitive function in risk-matched23 or
randomized24 patients undergoing CABG versus percutane-
ous coronary intervention or CABG versus noncardiac
surgical procedures.25 Measures of neurocognitive or neuro-
psychological function are inherently imprecise and prone to
a variety of systemic biases and confounders. Moreover,
there is no general agreement onwhich of themany available
tests are most appropriate,26 what would constitute a clini-
cally significant decline,27 or even how to best perform
statistical comparisons of test scores across multiple neuro-
psychological domains.28 Perhaps as a result of this method-
ological imprecision, single-center prospective studies have
reported ‘‘significant’’ decline relative to that seen in controlThe Journal of Thoracic and Carsubjects in neuropsychological performance ranging from
zero percent23 to 53%20 of patients after conventional
CABG during CPB.
Magnetic resonance imaging (MRI), especially with
diffusion-weighted techniques, has been the preferred im-
agingmodality to demonstrate acute cerebral emboli. None-
theless, the resolution of presently available scanners is
such that defects smaller than 1 mm are not detectable.
Moreover, the correlation between detection of new brain
lesions on MRI scanning and the appearance of new decline
in neurocognitive function has been disappointingly weak
in at least 1 previous small clinical series.29
The Surgical Management of Arterial Revascularization
Therapies (SMART) trial was conceived to rigorously com-
pare completeness of revascularization, clinical outcomes,
and resource use in unselected patients referred for elective
primary CABG randomly assigned to undergo OPCAB or
conventional CABG during CPB. Similar graft patency
was demonstrated between groups by means of coronary
angiographic analysis before hospital discharge and at the
1-year follow-up and by means of computed tomographic
angiographic analysis at a mean of 7.5 years of follow-
up.13,30,31 The principal secondary end points of the
SMART trial were neuroanatomic and neurocognitive
outcomes, as measured by using early and late diffusion-
weighted brain MRI and neuropsychological testing at
late follow-up. These results are the subject of this report.MATERIALS AND METHODS
Between March 2000 and August 2001, 297 unselected patients with
multivessel coronary artery disease were approached for voluntary enroll-
ment in the SMART trial. Two hundred of these 297 patients were ran-
domly assigned to undergo off-pump or on-pump coronary artery bypass
grafting by a single surgeon (J.D.P.). A single crossclamp was used in
the CPB group; partial occlusion clamping of the ascending aorta was
used for proximal anastomoses in the OPCAB group, when intraoperative
epiaortic ultrasound scanning of the ascending aorta revealed less than
grade 3 atherosclerosis. The sample size for the SMART trial was chosen
for the ability to detect a 5% absolute difference between groups in the pri-
mary end point of graft patency.
After a mean of 7.5 years (range, 6.8–8.4 years), 87 of the original partic-
ipants volunteered to return for late follow-up. As of March 30, 2009, there
were 26 deaths from all causes among patients undergoing OPCAB and
31 among patients undergoing CPB since initial enrollment. Reasons for
loss of patients to follow-up are listed in the consort flow diagram (Figure 1).
Neuropsychological Testing
Of the 87patients who returned for late follow-up, 76 (41 undergoing
CPB and 35 undergoing OPCAB) underwent a focused battery of neuro-
psychological tests to determine whether the surgical groups differed
with respect to cognitive function. The trained and certified neuropsycho-
logical test administrators were blinded to treatment assignment. Table 1
lists the neuropsychological test by domain. Each test is briefly described
below.
I. Attention.
A. Wechsler Memory Scale–3 Digit and Spatial Span: Patients listened
to sequences of digits and viewed sequences of spatial positions,diovascular Surgery c Volume 141, Number 5 1117
FIGURE 1. Consort flow diagram of SMART trial. OPCAB, Off-pump
coronary artery bypass; CABG, coronary artery bypass grafting; CPB, car-
diopulmonary bypass;MRI, magnetic resonance imaging; F/U, follow-up;
CTA, computed tomographic angiography; PET, positron emission tomog-
raphy; NP, neuropsychological.
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verse order. Scores are numbers of digits or spatial positions cor-
rectly reported in forward and backward sequence.
II. Memory function
A. Rey Auditory Verbal Learning Test (RAVLT): TheRAVLTuses a ver-
bally presented list learning task to measure immediate verbal
memory span, the ability to learn from repetition, and retention af-
ter a delay and an interpolated task. Scores are numbers or items
correct on the last of the 5 learning trials and the delayed recall trial.
B. Brief Visuospatial Memory Test–Revised: Patients attempt to draw
a series of designs from memory over 3 learning trials and again af-
ter a delay. The Brief Visuospatial Memory Test–Revised measures
immediate visual memory span, learning of nonverbal information,
and visual retention after a delay. Scores are the number of designs
recalled on the last of the 3 learning trials and the delayed recall
trial.
III. Executive and intellectual functions
A. Wechsler Abbreviated Scale of Intelligence: TheWechsler Abbrevi-
ated Scale of Intelligence provides an estimate of full-scale IQ
based on 2 subtests measuring vocabulary and nonverbal reasoning.
B. Booklet Category Test (Short Form): On each trial of this untimed
test, patients viewed a series of 4 pictured objects or designs to
determine a target principle for categorizing the stimuli. This testTABLE 1. Neuropsychological battery
I. Attention
A. Wechsler Memory Scale–3 Digit and Spatial Span
II. Memory
A. Rey Auditory Verbal Learning Test
B. Brief Visuospatial Memory Test–Revised
III. Executive and intellectual functions
A. Wechsler Abbreviated Scale of Intelligence (2 subtest)
B. Booklet Category Test (short form)
IV. Mood
A. Beck Depression Inventory–2
1118 The Journal of Thoracic and Cardiovascular Surassesses categorical reasoning, problem solving, and the ability to
learn from experience. The score reports the total number of errors.
IV. Mood
A. Beck Depression Inventory: A 21-item inventory providing a quan-
titative assessment of the intensity of functional depressive symp-
tomatology. It has been normed for adults, validated in the
literature, and widely used for research into depression in surgical
and nonsurgical disease states.Brain MRI Scanning and Image Interpretation
Early MRI of the brain was performed during the index hospitalization
on a Philips Gyroscan ACS-NT 1.5 T scanner. Late MRI images at long-
term follow-up were acquired on a GE Healthcare Signa HDx 1.5T MR
scanner. The axial T1-weighted, axial T2-weighted, axial fluid attenuated
inversion recovery (FLAIR), and axial diffusion-weighted images were in-
terpreted by a board-certified neuroradiologist.
Cerebral white matter lesions are identified by areas of abnormal hyper-
intensity in the T2-weighted or FLAIR images, which represent parenchy-
mal injury of predominately indeterminate acuity or chronicity. These
lesions are nonspecific and can be secondary to almost any pathologic pro-
cess, including ischemia, inflammation, infection, or neoplasm. Given the
relatively advanced age of the patients enrolled in this study, these lesions
most likely represent chronic microvascular ischemic changes, which tend
to increase in prevalence with age and are associated with common cardio-
vascular risk factors, such as hypertension. Diffusion abnormalities, de-
fined as areas of restricted diffusion, are also nonspecific but most
commonly associated with acute or subacute infarction.
White matter lesions and areas of diffusion abnormalities were inter-
preted according to a scoring system modified from the work by Scheltens
and colleagues32:
1. Temporal lobe atrophy and frontal lobe atrophy were each subjec-
tively graded on a scale from 0 (normal) to 4 (severe).
2. Hyperintense white matter lesions in either the T2-weighted or
FLAIR images were graded from 0 (normal) to 6 (severe), according
to the ordinal scale shown in Table 2.
3. Lesions with diffusion abnormality (acute or subacute infarctions)
were graded by using the same scale.
The late follow-up MRI images were scored by using the same scales
and supplemented with an additional score for periventricular lesions.
For purposes of scoring, periventricular lesions were defined as those in
contact with the ventricles. The thickness of the lesions was measured
along the lateral ventricles. Three separate scores were given for lesions ad-
jacent to the frontal horns of the lateral ventricles (anterior), adjacent to the
bodies (mid), and adjacent to the trigones (posterior; Table 3).
An additional quantitative image analysis was performed to compute re-
gional cerebrospinal fluid (CSF) volumes to quantitatively assess brain pa-
renchymal volume loss (atrophy). The images of the multiple pulse
sequences were spatially registered with each other, and a region of interest
(ROI) was manually drawn in the white matter of the corpus callosumTABLE 2. Ordinal scoring for white matter lesions
Score Lesion size Lesion no.
0 (normal)
1 All lesions are<4 mm <6
2 All lesions are<4 mm 6
3 The largest lesion measures between 4 and 10 mm <6
4 The largest lesion measures between 4 and 10 mm 6
5 At least 1 lesion is>10 mm
6 Severe confluent parenchymal signal abnormality
or transcortical territorial infarction is present
gery c May 2011
TABLE 3. Scoring for periventricular lesions
Score Lesion thickness
0 Normal
1 5 mm
2 >5 mm but 10 mm
3 >10 mm
FIGURE 2. Cross-sections of the regions of analysis in the brain. A, Seg-
mented imaged showing cerebrospinal fluid voxels in white. The anterior
frontal region of interest is outlined. Cross-sections through the regions
of interest superimposed on T2-weighted images: B, anterior frontal; C, an-
terior periventricular; D, peritrigonal; E, perisylvian; F, anterolateral tem-
poral; and G, anteromedial temporal.
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with the average white matter intensity computed from the ROI. Other
ROIs were drawn in the gray matter (thalamus) and CSF (lateral ventricles)
to obtain characteristic signal intensities. The ‘‘distance’’ d for each voxel
was then computed relative to the characteristic signal intensities. Analo-
gous equations defined the distances for graymatter (dGM) and white matter
(dWM). Segmented images were manually checked and corrected, such as
excluding the voxels representing fluid in the orbital globes. The volume
of CSF was then computed in groups of compartments corresponding to
the anterior frontal, frontal periventricular, anterolateral temporal, medial
temporal, perisylvian, and peritrigonal regions of the brain in a manner
similar to the work by Arimura et al33 (Figure 2).
BrainMRI scans were scored on ordinal scales with respect to diffusion-
weighted lesions, T2, temporal lobe atrophy, and frontal lobe atrophy.
Comparisons of OPCAB versus CABG during CPB with respect to these
scales were made for both early MRI studies (n ¼ 83 and n ¼ 85, respec-
tively) and late follow-up MRI (n ¼ 35 and n ¼ 32, respectively). Further-
more, for patients who had scans at both time points (n ¼ 27 and n ¼ 32,
respectively), the change in ordinal status was compared across groups to
see whether one group experienced statistically different changes over
time. All analyses of ordinal scales were made by using nonparametric
Wilcoxon tests.
The correlations between the neuropsychological test results and the
MRI findings were estimated by using the Spearman rank coefficient (the
nonparametric statistic was used because of the ordinal nature of the
MRI measurements). The previously described neuropsychological test re-
sults were analyzed for correlation with MRI findings at both baseline and
up to the 8-year follow-up. For patients who had MRI performed at both
time points, the neuroanatomic changes from baseline to follow-up were
correlatedwith neuropsychological test results. Furthermore, neuropsycho-
logical test results were examined for correlation with CSF volumes mea-
sured in 6 brain regions: anterior frontal lobes, frontal periventricular,
anterolateral temporal, medial temporal, perisylvian, and peritrigonal.
Statistical Analysis
To address concerns about selection bias in the present follow-up study,
c2 and t tests were performed to determine whether the means of clinical
risk factors of the returning group of SMART patients (1) differed accord-
ing to their original type of operation (OPCAB or conventional CABG) and
(2) differed from the original cohort in general. Furthermore, common con-
founders of cognitive effects, including age, sex, and IQ, were examined for
differences across groups. All analyses were performed with SAS Version
9.2 software (SAS Institute, Inc, Cary, NC). All tests were evaluated at the
.05 significance level. No adjustments for multiple tests were performed.
RESULTS
Among the 41 patients undergoing CPB and 35 patients
undergoing OPCAB tested for cognitive function, the
mean age was 66.7 years (range, 38–90 years). Patients un-
dergoing OPCAB (mean, 64.9 years; range, 38–90 years)
were younger than patients undergoing CPB (mean, 68.3
years; range, 52–89 years), but the difference was not statis-
tically different (P ¼ .14). Nine (22.0%) patients undergo-The Journal of Thoracic and Caring CPB and 8 (22.9%) patients undergoing OPCAB were
female (P¼ .92). The groups were also similar with respect
to all preoperative clinical characteristics (Table 4). The pa-
tients who returned for follow-up were not significantly
different either between groups at follow-up or compared
with the original groups at the time of randomization.diovascular Surgery c Volume 141, Number 5 1119
TABLE 4. Comparison of preoperative characteristics of the original patient cohort and the subset who underwent follow-up NP study
Characteristic
Original SMART study (n ¼ 197) SMART NP study follow-up (n ¼76)
CABG during
CPB (n ¼ 99)
OPCAB
(n ¼ 98) P value
CABG during
CPB (n ¼ 41)
OPCAB
(n ¼ 35)
P
value
Age at enrollment (mean  SD) 62.5 (9.5) 62.1 (11.1) 0.82 60.8 (8.8) 57.5 (10.8) .14
Female sex (%) 23 (23) 22 (22) 0.90 9 (22.0) 8 (22.9) .92
Baseline ejection fraction (%)
>55% 49 (51) 52 (54) 0.78 21 (52.5) 21 (60.0) .86
45%–54% 22 (23) 21 (22) 10 (25.0) 8 (22.9)
35%–44% 11 (11) 15 (15) 6 (15.0) 4 (11.4)
25%–34% 7 (7) 5 (5) 1 (2.5) 0 (0.0)
<25% 6 (6) 4 (4) 2 (5.0) 2 (5.7)
Previous MI (%) 31 (31) 34 (35) 0.61 13 (31.7) 12 (34.4) .81
Previous CVA (%) 9 (9) 1 (1) 0.01 3 (7.3) 0 (0.0) .10
Previous TIA (%) 1 (1) 3 (3) 0.31 1 (2.4) 1 (2.9) .91
COPD (%) 8 (8) 10 (10) 0.61 2 (4.9) 0 (0.0) .19
Current smoker (%) 31 (31) 27 (28) 0.56 10 (24.4) 8 (22.9) .88
Diabetes (%) 33 (33) 32 (33) 0.96 17 (41.5) 10 (28.6) .24
Diet 21 (21) 24 (24) 0.58 10 (24.4) 6 (17.1) .44
Insulin 10 (10) 9 (9) 0.83 6 (14.6) 5 (14.3) .97
Oral 24 (24) 22 (22) 0.77 11 (26.8) 5 (14.3) .18
Hypertension (%) 61 (62) 64 (65) 0.59 28 (68.3) 22 (62.9) .62
Angioplasty (%) 15 (15) 23 (23) 0.14 9 (22.0) 8 (22.9) .92
Stent (%) 6 (6) 9 (9) 0.41 4 (9.8) 5 (14.3) .54
Hypercholesterolemia (%) 47 (47) 48 (49) 0.83 21 (51.2) 16 (45.7) .63
PVD (%) 10 (10) 13 (13) 0.49 3 (7.3) 2 (5.7) .78
Renal failure (%) 4 (4) 2 (2) 0.41 0 (0.0) 0 (0.0) 1.0
Dialysis dependent (%) 1 (1) 1 (1) 0.99 0 (0.0) 0 (0.0) 1.0
NYHA class III or IV (%) 1 (1) 2 (2) 0.38 1 (2.4) 0 (0.0) .62
CCS class III or IV (%) 12 (12) 24 (25) 0.12 5 (12.2) 10 (28.6) .22
NP, Neuropsychological; SMART, Surgical Management of Arterial Revascularization Therapies; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass;
OPCAB, off-pump coronary artery bypass; SD, standard deviation; MI, myocardial infarction; CVA, cerebrovascular accident; TIA, transient ischemic attack; COPD, chronic
obstructive pulmonary disease; PVD, peripheral vascular disease; NYHA, New York Heart Association; CCS, Canadian Cardiovascular Society.
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tically similar between the CPB and OPCAB groups (96.2
vs 101.4, P ¼ .21).
Table 5 summarizes the analyses of the neuropsycholog-
ical test results, which were performed only once, at a mean
of 7.5 years of follow-up. Statistically significant differ-
ences between groups were seen primarily on tests of exec-
utive function. Although the magnitudes of the differences
are small, patients undergoing OPCAB obtained higher
scores on Spatial Span Backward and made fewer errors
on the Short Category Test. Patients undergoing OPCAB
also tended to remember more items from the RAVLT by
the final learning trial, although the difference between
groups was not statistically significant. A comparison of
neuropsychological function after OPCAB versus CPB
among diabetic patients is presented in Table 6. In all 13
neuropsychological tests the mean performance score for
patients with OPCAB was superior to that of patients with
CPB. Perhaps because of the small diabetic sample size at
follow-up (10 patients undergoing OPCAB vs 17 patients
undergoing CPB), none of these individual test scores
were statistically significant.1120 The Journal of Thoracic and Cardiovascular SurTable 7, shows the findings of early MRI among 168 pa-
tients and late MRI among 67 patients. Early MRI in 168
patients showed no significant differences between surgical
treatment groups in atrophy, subcortical white matter le-
sions, or acute infarctions. Among 59 patients who had
both early and late MRI, there were no significant differ-
ences between surgical treatment groups with respect to at-
rophy over time or new subcortical white matter lesions or
infarctions. Interestingly, there were significantly more
diffusion-weighted abnormalities in subcortical white mat-
ter (new cerebral infarctions) among patients with diabetes
than among patients without diabetes in both surgical treat-
ment groups (Table 8) early after surgical intervention.
Moreover, although baseline atrophy scores were similar
for diabetic and nondiabetic patients early after surgical in-
tervention, there was significantly greater cerebral atrophy
at follow-up and a significantly greater increase in atrophy
between baseline and follow-up among diabetic patients
than among nondiabetic patients. However, there were sta-
tistically similar numbers of new diffusion-weighted abnor-
malities in subcortical white matter among diabetic patients
who had CPB and those who had OPCAB. Atrophy over 7.5gery c May 2011
TABLE 5. Neuropsychological test comparison between surgical groups at a mean of 7.5 years of follow-up
Domain Variable CPB (n ¼ 41) OPCAB (n ¼ 35) P value
Attention Digit Span Forward 6.07 (1.19) 6.34 (1.39) .37
Attention Digit Span Backward 4.15 (1.15) 4.57 (1.44) .16
Attention Spatial Span Forward 5.00 (1.07) 5.03 (1.20) .91
Attention Spatial Span Backward 4.39 (1.0) 5.03 (1.12) .011
Memory RAVLT Trial 5 9.07 (2.39) 10.23 (2.88) .06
Memory RAVLT Delayed Recall 6.68 (2.56) 7.54 (3.33) .21
Memory BVMT-R Trial 3 6.61 (3.37) 6.86 (3.16) .74
Memory BVMT Delayed Recall 5.98 (3.04) 6.40 (3.26) .56
Executive/Intellectual WASI Full-Scale IQ 96.2 (17.7) 101.4 (18.0) .21
Executive/Intellectual WASI Vocabulary IQ 9.4 (3.5) 10.3 (3.4) .27
Executive/Intellectual WASI Matrix IQ 8.9 (4.1) 10.0 (3.8) .22
Executive/Intellectual Short Category Test Errors 45.6 (11.2) 39.5 (14.9) .05
Mood Beck Depression Inventory 6.4 (5.3) 6.5 (8.4) .95
Data are presented as means (standard deviations). CPB, Cardiopulmonary bypass; OPCAB, off-pump coronary artery bypass; RAVLT, Rey Auditory Verbal Learning Test;
BVMT-R, Brief Visuospatial Memory Test–Revised; WASI, Wechsler Abbreviated Scale of Intelligence.
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had CPB and those who had OPCAB (Table 9).
The first 4 rows of Table 10 show the correlation between
baseline (early) brain MRI and neuropsychological test
result at late follow-up. Correlational analyses were done
specifically on neuropsychological tests for which a statisti-
cally significant difference (or trend toward a significant
difference) in scores was found between the CPB and OP-
CAB groups. At baseline, these findings indicate that pa-
tients with greater degrees of frontal atrophy performed
less well on theWechsler Memory Scale Spatial Span Back-
wards score (r ¼0.29, P ¼ .024) and the number of Short
Category Test errors (r ¼ 0.32, P ¼ .012), again indicating
that impaired cognitive test performance is associated with
cerebral atrophy.
The middle 4 rows of Table 10 show correlation between
brain MRI images at late follow-up and neuropsychological
test results at late follow-up. At follow-up, significant asso-
ciations were seen between temporal lobe atrophy and both
the Wechsler Memory Score (r ¼0.27, P ¼ .041) and theTABLE 6. Neuropsychological findings among patients with diabetes
Domain Variable
Attention Digit Span Forward
Attention Digit Span Backward
Attention Spatial Span Forward
Attention Spatial Span Backward
Memory RAVLT Trial 5
Memory RAVLT Delayed Recall
Memory BVMT-R Trial 3
Memory BVMT Delayed Recall
Executive/Intellectual WASI Full-Scale IQ
Executive/Intellectual WASI Vocabulary IQ
Executive/Intellectual WASI Matrix IQ
Executive/Intellectual Short Category Test Errors
Mood Beck Depression Inventory
Data are presented as means (standard deviations). CPB, Cardiopulmonary bypass; OPC
BVMT-R, Brief Visuospatial Memory Test–Revised; WASI, Wechsler Abbreviated Scale o
The Journal of Thoracic and CarRAVLT-5 (r ¼0.30, P ¼ .021), indicating that increased
atrophy does indeed result in diminished cognitive abilities.
Similarly, frontal lobe atrophy was significantly related to
the Wechsler Memory Score (r ¼ 0.41, P ¼ .002) and
the number of Short Category Test errors (r ¼ 0.32,
P ¼ .012), again indicating that cognitive abilities are af-
fected by atrophy.
The last 4 rows of Table 10 show correlation between
changes in brain MRI findings from early baseline to late
follow-up with neuropsychological testing at late follow-
up. The change in brain atrophy from baseline to follow-
up was not associated with any neuropsychological test
findings in this limited patient sample.
Of note is the finding that the surgical groups did not dif-
fer with respect to measures of CSF volumes, which serve as
a more quantitative measure of cerebral atrophy. Moreover,
the 2 different measures of cerebral atrophy used in the pres-
ent study (ie, ordinal scale estimates and quantitative CSF
assessment) correlated highlywith each other and correlated
similarly with neuropsychological outcomes. There wereCPB (n ¼ 17) OPCAB (n ¼ 10) P value
6.12 (1.32) 6.90 (1.29) .15
4.41 (1.33) 4.90 (1.73) .42
5.06 (0.97) 5.10 (1.45) .93
4.18 (1.13) 5.00 (0.94) .06
8.41 (2.24) 10.2 (2.82) .08
6.12 (2.42) 7.40 (3.53) .27
6.24 (3.21) 7.2 (3.55) .48
5.82 (3.28) 6.10 (3.41) .84
94.8 (16.5) 104.7 (20.2) .18
9.41 (3.47) 10.6 (3.92) .42
8.53 (4.14) 10.8 (3.94) .17
46.5 (10.7) 37.1 (15.3) .07
6.6 (4.1) 9.1(11.5) .52
AB, off-pump coronary artery bypass; RAVLT, Rey Auditory Verbal Learning Test;
f Intelligence.
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TABLE 7. Results of brain MRI studies scored on ordinal scales
Variable
Early postoperative brain MRI MRI at late follow-up Change: Follow-up—baseline
CPB
(n ¼ 85)
OPCAB
(n ¼ 83)
Wilcoxon
P value
CPB
(n ¼ 35)
OPCAB
(n ¼ 32)
Wilcoxon
P value
CPB
(n ¼ 27)
OPCAB
(n ¼ 32)
Wilcoxon
P value
DWI 0.73 0.88 .37 0.09 0.00 .36 0.84 0.67 .59
T2 1.93 2.22 .38 3.49 3.88 .23 1.88 1.85 .93
Temporal atrophy 0.54 0.49 .36 0.89 0.97 .87 0.59 0.48 .64
Frontal atrophy 0.41 0.59 .09 0.91 0.72 .29 0.53 0.44 .56
Perivent
frontal
— — — 1.30 1.38 .70 — — —
Perivent
posterior
— — — 1.29 1.71 .13 — — —
Perivent
lateral
— — — 1.06 1.19 .51 — — —
All numeric values are means of ordinal scales within each surgical group.MRI, Magnetic resonance imaging;CPB, cardiopulmonary bypass;OPCAB, off-pump coronary artery
bypass; DWI, diffusion-weighted abnormalities in subcortical white matter; T2, T2-weighted or fluid attenuated inversion recovery signal abnormalities in subcortical white mat-
ter; Temporal atrophy, atrophic changes in temporal lobe (subjective ordinal scale); Frontal atrophy, atrophic changes in frontal lobe (subjective ordinal scale); Perivent frontal,
thickness of lesions present in the periventricular white matter adjacent to the frontal horns; Perivent posterior, thickness of lesions present in the periventricular white matter
adjacent to the posterior trigones; Periventricular lateral, thickness of lesions present in the periventricular white matter adjacent to the midlateral portion of the ventricles.
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chological tests of moderate strength. Significant correla-
tions were found between the Spatial Span Backwards
score and frontal periventricular volume (r ¼ 0.29,
P ¼ .017) and peritrigonal volume (r ¼0.30, P ¼ .013).
Also, significant associations exist between the RAVLT-5
score and frontal periventricular volume (r ¼ 0.25,
P ¼ .042), anterolateral temporal volume (r ¼ 0.30,
P ¼ .012), medial temporal volumes (r ¼ 0.35,
P ¼ .004), and peritrigonal volume (r ¼0.29, P ¼ .018).
No significant correlations were detected between the Short
Category Test Errors and any CSF region (Table 11).
DISCUSSION
The present prospective randomized trial is the largest
US trial of OPCAB with angiographic graft assessment
and longer-term follow-up of neuroanatomic and neuropsy-TABLE 8. Results of brain MRI studies scored on ordinal scales by diabe
Variable
Early postoperative brain MRI MR
Diabetes,
no (n ¼ 110)
Diabetes,
yes (n ¼ 58)
Wilcoxon
P value
Diabetes,
no (n ¼ 46)
DWI 0.55 1.29 .009 0.0
T2 1.94 2.33 .21 3.5
Frontal atrophy 0.48 0.51 .74 0.80
Temporal atrophy 0.51 0.53 .95 0.78
Perivent
frontal
— — — 1.39
Perivent
posterior
— — — 1.49
Perivent
lateral
— — — 1.02
All numeric values are means of ordinal scales within each surgical group.MRI, Magnetic re
T2, T2-weighted or fluid attenuated inversion recovery signal abnormalities in subcortica
scale); Temporal atrophy, atrophic changes in temporal lobe (subjective ordinal scale); Per
to the frontal horns; Perivent posterior, thickness of lesions present in the periventricular
present in the periventricular white matter adjacent to the mid-lateral portion of the ventr
1122 The Journal of Thoracic and Cardiovascular Surchological outcomes. Survivors voluntarily returned at
a mean of 7.5 years for formal neuropsychological testing
and brain MRI. Of 200 patients initially randomized, 76
(41 undergoing CPB and 35 undergoing OPCAB) had neu-
ropsychological testing at late follow-up. Groups were sim-
ilar with respect to potential confounders, such as age, sex,
depression, and IQ, both at enrollment and at long-term fol-
low-up.
At late follow-up, patients undergoing OPCAB showed
better attention, performing better at simultaneously tracking
and mentally manipulating visual information (P ¼ .011).
Patients undergoing OPCAB showed a trend toward better
verbal learning (P¼ .064). There were no significant differ-
ences between groups in visuospatial memory. Patients un-
dergoing OPCAB showed better cognitive reasoning,
making fewer errors in reasoning (P ¼ .05). There were no
domains in which patients undergoing CPB outperformedtes status
I at late follow-up Change: Follow-up–baseline
Diabetes,
yes (n ¼ 21)
Wilcoxon
P value
Diabetes,
no (n ¼ 41)
Diabetes,
yes (n ¼ 18)
Wilcoxon
P value
0.14 .15 0.73 0.83 .98
4.05 .29 2.02 1.50 .27
0.86 .80 0.51 0.44 .67
1.24 .059 0.29 1.11 .004
1.24 .34 — — —
1.52 .98 — — —
1.33 .13 — — —
sonance imaging;DWI, diffusion-weighted abnormalities in subcortical white matter;
l white matter; Frontal atrophy, atrophic changes in frontal lobe (subjective ordinal
ivent frontal, thickness of lesions present in the periventricular white matter adjacent
white matter adjacent to the posterior trigones; Perivent lateral, thickness of lesions
icles.
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TABLE 9. Results of brain MRI studies among patients with diabetes
Variable
Early postoperative brain MRI MRI at late follow-up Change: Follow-up–baseline
CPB
(n ¼ 29)
OPCAB
(n ¼ 29)
Wilcoxon
P value
CPB
(n ¼ 11)
OPCAB
(n ¼ 7)
Wilcoxon
P value
CPB
(n ¼ 11)
OPCAB
(n ¼ 7)
Wilcoxon
P value
DWI 1.14 1.45 .68 0.27 0.00 .50 0.36 1.57 .31
T2 2.14 2.52 .58 4.36 4.14 .88 1.73 1.14 .44
Atrophy 0.41 0.55 .25 1.00 0.71 .48 0.55 0.29 .48
TT 0.55 0.52 .53 1.18 1.71 .26 0.82 1.57 .17
MRI, Magnetic resonance imaging; CPB, cardiopulmonary bypass; OPCAB, off-pump coronary artery bypass; DWI, diffusion-weighted abnormalities in subcortical white
matter; T2, T2-weighted or fluid attenuated inversion recovery signal abnormalities in subcortical white matter; TT, temporal tip atrophy.
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patients undergoing OPCAB had better preserved executive
function. However, these differences were relatively small,
in the range of 12% to 15%, and none met the benchmark
of a 20% difference, which is frequently considered in the
literature to be clinically significant.27,34
A strong relative benefit of off-pump techniques over
conventional CABG during CPB with respect to neurocog-
nitive outcomes has been reported in several single-center
prospective trials. Among 40 randomized patients, Diegeler
and associates35 reported that emboli detected in the middle
cerebral artery during OPCAB were fewer than during con-
ventional CABG; postoperative serum levels of the neuro-
biochemical marker protein S-100 were correspondingly
lower and neurocognitive function better in patients ran-
domized to OPCAB than to conventional CABG during
CPB. Zamvar and colleagues36 randomized 60 patients
and reported neurocognitive impairment at 1 week postop-
eratively in 27% of patients undergoing OPCAB and 63%
of patients undergoing CPB; at 10 weeks postoperatively,
10% of patients undergoing OPCAB and 40% of patients
undergoing CPB showed impairment during neurocognitive
testing.
Van Dijk and coworkers37 randomized 281 patients to
OPCAB versus CPB and reported improved cognitive out-TABLE 10. Spearman rank correlations between selected NP tests and M
MRI finding Time period
Wechsler
Memory Sco
DWI Baseline 0.16 (P ¼ .2
T2 Baseline 0.13 (P ¼ .3
Frontal atrophy Baseline 0.29 (P ¼ .0
Temporal tip atrophy Baseline 0.05 (P ¼ .7
DWI Follow-up 0.09 (P ¼ .5
T2 Follow-up 0.07 (P ¼ .6
Frontal atrophy Follow-up 0.41 (P ¼ .0
Temporal tip atrophy Follow-up 0.27 (P ¼ .0
DWI Change 0.14 (P ¼ .3
T2 Change 0.09 (P ¼ .5
Frontal atrophy Change 0.23 (P ¼ .0
Temporal tip atrophy Change 0.17 (P ¼ .1
NP, Neuropsychological; MRI, magnetic resonance imaging; DWI, diffusion-weighted abn
recovery signal abnormalities in subcortical white matter; Frontal atrophy, atrophic chan
temporal lobe (subjective ordinal scale).
The Journal of Thoracic and Carcomes 3 months after the procedure, but these effects
were small and became negligible at 12 months.
Al-Ruzzeh and associates38 randomized 168 patients and
found those who underwent OPCAB showed better neuro-
cognitive function at 6 weeks and 6 months postoperatively
compared with those who underwent CABG during CPB.
However, the subset of 120 randomized patients in the
Best Bypass Surgery trial who had neuropsychological test-
ing preoperatively and postoperatively did not demonstrate
any significant difference in the incidence of cognitive dys-
function 3 months after either OPCAB or CPB.39 Similarly,
201 patients randomized by Hernandez and colleagues40 to
have OPCAB versus CPB demonstrated no significant dif-
ference in the incidence of neurocognitive deficits 6 months
after surgical intervention. Lund and coworkers41 reported
a large, statistically significant difference between OPCAB
and CPB in cerebral microemboli detected by means of
transcranial Doppler ultrasonographic analysis among 120
randomized patients but no significant difference in neuro-
psychological performance between groups nor any corre-
lation between the number of cerebral microemboli and
the degree of neurocognitive dysfunction. Similarly, Liu
and associates42 compared intraoperative cerebral micro-
emboli and neuropsychological function between matched
cohorts undergoing OPCAB versus CPB and found thatRI findings
re
Rey Auditory Verbal
Learning Test
Short Category
Test Errors
3) 0.16 (P ¼ .22) 0.13 (P ¼ .33)
1) 0.16 (P ¼ .23) 0.20 (P ¼ .14)
24) 0.03 (P ¼ .85) 0.18 (P ¼ .17)
2) 0.04 (P ¼ .78) 0.26 (P ¼ .046)
0) 0.14 (P ¼ .30) 0.04 (P ¼ .75)
2) 0.14 (P ¼ .29) 0.07 (P ¼ .59)
02) 0.10 (P ¼ .44) 0.32 (P ¼ .012)
41) 0.30 (P ¼ .021) 0.19 (P ¼ .14)
0) 0.13 (P ¼ .32) 0.13 (P ¼ .32)
0) 0.002 (P ¼ .98) 0.22 (P ¼ .10)
7) 0.12 (P ¼ .35) 0.23 (P ¼ .09)
9) 0.25 (P ¼ .052) 0.008 (P ¼ .95)
ormalities in subcortical white matter; T2, T2-weighted or fluid attenuated inversion
ges in frontal lobe (subjective ordinal scale); Temporal atrophy, atrophic changes in
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TABLE 11. Spearman rank correlation coefficients between selected NP tests and CSF volumes at late follow-up
CSF region
Wechsler
Memory Score
Rey Auditory Verbal
Learning Test
Short Category
Test Errors
Anterior frontal lobes 0.06 (P ¼ .61) 0.10 (P ¼ .40) 0.04 (P ¼ .75)
Frontal periventricular 0.29 (P ¼ .017) 0.25 (P ¼ .042) 0.05 (P ¼ .70)
Anterolateral temporal 0.14 (P ¼ .25) 0.30 (P ¼ .012) 0.06 (P ¼ .64)
Medial temporal 0.13 (P ¼ .28) 0.35 (P ¼ .004) 0.02 (P ¼ .90)
Perisylvian 0.14 (P ¼ .26) 0.15 (P ¼ .23) 0.03 (P ¼ .79)
Peritrigonal 0.30 (P ¼ .013) 0.29 (P ¼ .018) 0.03 (P ¼ .82)
NP, Neuropsychological; CSF, cerebrospinal fluid.
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microemboli, but similar incidence of neuropsychological
dysfunction.
The finding in the present study that neuropsychological
function was superior in patients who have hadOPCAB ver-
sus conventional CABGduring CPB is consistent with some
previous reports12,35,36 but inconsistent with others.40-42 The
relatively small sample size and absence of baseline
preoperative neuropsychological testing in the present
study render these findings additive to the literature rather
than conclusive or definitive.
Before discharge from the index surgical hospitalization,
diffusion-weighted brain MRI in 168 patients showed no
significant differences between groups in atrophy, subcorti-
cal white matter lesions, or acute infarctions. Among 59 pa-
tients who had brain MRI both at the index hospitalization
and at a mean of 7.5 years of follow-up, there were no sig-
nificant differences between groups with respect to atrophy
over time or new subcortical white matter lesions or infarc-
tions. These findings are consistent with those of Lund and
colleagues,29 who reported a similar incidence of new post-
operative cerebral lesions in 120 patients randomized to
OPCAB versus CPB imaged with brain MRI at 3 months
postoperatively.
The present study includes 168 diffusion brain MRI stud-
ies early after randomization to OPCAB versus CABG dur-
ing CPB. This is the largest such dataset extant and, as such,
has the opportunity to add meaningfully to our understand-
ing of the effect of CPB on neuroanatomic outcomes in pa-
tients undergoing surgical coronary revascularization. Of
primary interest is the fact that very few patients had any
new cerebral infarctions detectable by means of brain
MRI after coronary bypass either with or without CPB.
This reflects a paucity of emboli of sufficient size to be de-
tectable by means of currently available MRI imaging.
Nonetheless, if the neuropsychological differences ob-
served between surgical groups in the present study and in
several previous studies are the result of fewer embolic
events after OPCAB than after CABG during CPB, then
one must assume that neurocognitive decline might be
caused by emboli too small to be detected by means of
MRI scanning. Alternatively, there might be other ways in
which CPB impairs postoperative cerebral function. Such1124 The Journal of Thoracic and Cardiovascular Surputative mechanisms might include the systemic inflamma-
tory response, hemodilution, hypothermia, and nonspecific
metabolic derangements. Such nonembolic cerebral impair-
ment might be expected to resolve over a period of weeks or
months. Indeed, several studies have reported a neurocogni-
tive benefit of OPCAB over CPB early after surgical inter-
vention but no difference at 6 to 12 months.43,44 Although
diffusion-weighted brain MRI can distinguish between re-
cent cerebral infarctions (around which localized edema is
evident) and old cerebral infarctions (which lack edema)
but has poor resolution to detect very small emboli and
does not image metabolic dysfunction, which might exist
after microembolic injury in the absence of detectible cere-
bral infarction.
More rapid progression of brain atrophy and cognitive
decline in nonsurgical patients with diabetes mellitus
compared with nondiabetic patients has been previously re-
ported.45 Moreover, white matter changes predict cognitive
decline in elderly nonsurgical patients.46 The finding in the
present study that diabetic patients had significantly more
acute perioperative cerebral infarctions by means of brain
MRI than nondiabetic patients and worse atrophy at late
follow-up after CABG has not been previously reported.
It is possible that diabetic vasculopathy in both extracranial
and intracerebral vessels predisposes diabetic patients to
greater risk of macroemboli and microemboli during car-
diac surgery, irrespective of the use or avoidance of CPB.
Moreover, the absence of any difference in infarctions or at-
rophy between surgical treatment groups among diabetic
patients might reflect the use of an aortic clamp in both
groups. Interestingly, the association of cognitive impair-
ment with brain MRI measures has been equivocal in non-
surgical patient populations as well.47
Limitations
The present study has several important limitations,
including a small sample size. Despite the absence of any
significant difference in the means of the clinical character-
istics of the randomized patient groups at baseline, at late
follow-up, or within surgical groups compared between
baseline and follow-up, the large attrition between enroll-
ment and late follow-up introduces the potential for impor-
tant selection bias for which no adjustment is possible. Thegery c May 2011
Puskas et al Acquired Cardiovascular Disease
A
C
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vention or at early follow-up limits the strength of compar-
isons between groups over time.
CONCLUSIONS
After a mean of 7.5 years of follow-up in this randomized
trial, OPCAB was associated with better performance in
some neuropsychological domains compared with CPB,
primarily on tests of executive function. These differences
are of uncertain clinical significance. Early diffusion-
weighted brain MRI showed no significant differences in
acute cerebral infarctions between the OPCAB and CPB
groups but more frequent lesions among diabetic patients
in both groups. Temporal and frontal lobe cerebral atrophy
demonstrated by early or late MRI scanning correlated with
impaired neuropsychological function in both groups. How-
ever, repeat MRI at late follow-up showed interval atrophic
changes that were worse in patients with diabetes but simi-
lar between surgical groups.
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Dr John W. Hammon, Jr (Winston-Salem, NC). Thank you
very much. John, that was an excellent presentation, as usual,
and what we have come to expect from you. I personally admire
your tenacity in following your early hypothesis that off-pump sur-
gical intervention was superior to on-pump surgical intervention
and your attempts to show us why. I think we all appreciate that
there are some definite advantages of off-pump surgical interven-
tion. Let’s talk about the secondary end points that you reported
today.
I think you are particularly to be congratulated on having the
largest series of brain MRI studies done early postoperatively in
these 2 groups of patients, and I think your disappointment in find-
ing that there are no differences needs to be discussed a little bit
further. Therefore my first question is this: If you took high-risk
groups of patients for brain infarction after surgical intervention
(ie, patients who had previous stroke or perhaps diabetes) and
teased those out, did you find any differences in those groups of
patients?
Dr Puskas. We did look at nondiabetic versus diabetic
patients and found no significant difference between off-pump1126 The Journal of Thoracic and Cardiovascular Surand on-pump surgical intervention in either nondiabetic or diabetic
patients.
Dr Hammon. Did you find any differences in the total group
between diabetic and nondiabetic patients?
Dr Puskas. We did not do that specific P value that I can recall.
Dr Hammon. You might want to do that because I would bet
that there would be some differences.
The second item of business is neuropsychological studies. You
have been very honest and reported the deficiencies in your group,
which was small, and the fact that you got statistical significance
means something. Thereforewhat exactly does itmean?Bynot hav-
ing a baseline study, it is very difficult to say that the groups were
similar. Some of the neuropsychological tests are very significantly
affected by the amount of learning that persons have, and I do not
remember in reading your abstract or your article that you had en-
tered that variable in the preoperative characteristics. That is some-
thing you might want to look at, because particularly in executive
function, people who have higher learning do better on those tests.
Nevertheless, it is a very good study and adds immensely to our
knowledge of this subject, and I congratulate you.
Dr Puskas. Thank you, Dr Hammon. We did correct for the
level of education in our assessment of the neuropsychological
outcomes, but undoubtedly, the single greatest deficit of the design
of this study, and it is clearly my fault, is that we did not perform
preoperative neuropsychological testing 10 years ago or 8½ years
ago now. We actually designed the trial initially to do preoperative
neuropsychological testing and early postoperative diffusion-
weighted brain MRI scanning, but we found that the inability to
get a PhD neuropsychologist to show up at 6 PM the night before
the operation was a show stopper. We could not enroll patients.
Therefore we decided that we would jettison that to get the trial
done, and therefore after about 2 weeks we gave up; probably
my characteristic tenacity failed me at that point. We should
have done that, but I cannot go back 8 years.
Dr Lawrence H. Cohn (Boston, Mass). John, let me ask you
a question. Youmight have said this and I apologize for not reading
your extensive bibliography, but have you shown in the semiacute
phase, such as 3 months or 1 year, imaging differences like you
tried to show today?
Dr Puskas. The next largest series of brain MRI scans after car-
diac surgery was published in 2005 by Lund. He randomized 120
patients to off-pump and on-pump surgical intervention and did
a single study, which was a brain MRI, actually a single brain
MRI study at 3 months, and he found no difference in diffusion-
weighted changes at that time or atrophic changes. I think the bot-
tom line is that brain MRI does not have a resolution adequate to
detect small emboli or other factors that affect how we think and
function cognitively. It is just too blunt a tool.
DrHammon. You keep mentioning emboli as the cause ofMRI
lesions. We have done a number of studies in our laboratory on
what causes MRI lesions, and in about half of them, there is no
known cause. Therefore I think to refer to them as embolic lesions
is probably not correct. I think you need to call them infarcts.
Dr Puskas. Fair enough. I think that is absolutely well taken.
That is probably why, John, the several very small studies have
failed to demonstrate a correlation between intraoperative, trans-
cranial, Doppler high-intensity transient signals in themiddle cere-
bral artery and subsequent early postoperative, diffusion-weightedgery c May 2011
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DMRI scans. That in and of itself is a real paradox unless you accept
the fundamental notion that not all cerebral infarcts or microin-
farcts are caused by emboli.
Dr Juergen Carl Ennker (Lahr, Germany). Congratulations,
Dr Puskas, for this very outstanding study, which again underlines
the importance of the OPCAB technique, which is absolutely nec-
essary after the ROOBY study. I have a technical question. I would
have expected an even larger benefit for patients undergoing OP-
CAB. My question is this: Did you use a no-touch aortic technique
in your patients undergoing OPCAB, such as by using T grafts?
Dr Puskas. That is a great question. In the year 2000, when we
were doing these operations,, we did not have the same attention to
avoiding the ascending aorta that we do now. Therefore the large
majority of patients in both the off-pump and on-pump groups
had some form of clamp on the ascending aorta. You know that
the Heartstring and other proximal anastomotic devices were not
available in 2000, and therefore the vast majority of patients under-
going off-pump surgery had a partial occlusion clamp on the as-The Journal of Thoracic and Carcending aorta unless their intraoperative epiaortic ultrasound
demonstrated significant ascending aortic atheroma, in which
case they had a no-touch technique in both groups.
Dr Carlos A. Mestres (Barcelona, Spain). Dr Puskas, just one
last quick thing. Of course you have mentioned the limitations of
your work. In your conclusions you said that you found just
a ‘‘modest’’ superiority. The point is this: Was this what you ex-
pected? Of course, this is not science, but give us your gut feeling.
Dr Puskas. There are several studies in the literature that
would argue that a clinically significant difference in neuropsy-
chological outcomes requires a 20% change or difference in at
least 20% of the domains tested. We had a statistically significant
difference in more than 20% of the domains tested, but none of
those differences actually reached an absolute 20% decrement
or difference between the 2 groups. Of course, what is clinically
significant matters differently to different patients: manual dexter-
ity matters more to a violinist and cognitive reasoning matters
more to a physicist.diovascular Surgery c Volume 141, Number 5 1127
